Calendar An icon of a desk calendar. Cancel An icon of a circle with a diagonal line across. Caret An icon of a block arrow pointing to the right. Email An icon of a paper envelope. Facebook An icon of the Facebook "f" mark. Google An icon of the Google "G" mark. Linked In An icon of the Linked In "in" mark. Logout An icon representing logout. Profile An icon that resembles human head and shoulders. Telephone An icon of a traditional telephone receiver. Tick An icon of a tick mark. Is Public An icon of a human eye and eyelashes. Is Not Public An icon of a human eye and eyelashes with a diagonal line through it. Pause Icon A two-lined pause icon for stopping interactions. Quote Mark A opening quote mark. Quote Mark A closing quote mark. Arrow An icon of an arrow. Folder An icon of a paper folder. Breaking An icon of an exclamation mark on a circular background. Camera An icon of a digital camera. Caret An icon of a caret arrow. Clock An icon of a clock face. Close An icon of the an X shape. Close Icon An icon used to represent where to interact to collapse or dismiss a component Comment An icon of a speech bubble. Comments An icon of a speech bubble, denoting user comments. Comments An icon of a speech bubble, denoting user comments. Ellipsis An icon of 3 horizontal dots. Envelope An icon of a paper envelope. Facebook An icon of a facebook f logo. Camera An icon of a digital camera. Home An icon of a house. Instagram An icon of the Instagram logo. LinkedIn An icon of the LinkedIn logo. Magnifying Glass An icon of a magnifying glass. Search Icon A magnifying glass icon that is used to represent the function of searching. Menu An icon of 3 horizontal lines. Hamburger Menu Icon An icon used to represent a collapsed menu. Next An icon of an arrow pointing to the right. Notice An explanation mark centred inside a circle. Previous An icon of an arrow pointing to the left. Rating An icon of a star. Tag An icon of a tag. Twitter An icon of the Twitter logo. Video Camera An icon of a video camera shape. Speech Bubble Icon A icon displaying a speech bubble WhatsApp An icon of the WhatsApp logo. Information An icon of an information logo. Plus A mathematical 'plus' symbol. Duration An icon indicating Time. Success Tick An icon of a green tick. Success Tick Timeout An icon of a greyed out success tick. Loading Spinner An icon of a loading spinner. Facebook Messenger An icon of the facebook messenger app logo. Facebook An icon of a facebook f logo. Facebook Messenger An icon of the Twitter app logo. LinkedIn An icon of the LinkedIn logo. WhatsApp Messenger An icon of the Whatsapp messenger app logo. Email An icon of an mail envelope. Copy link A decentered black square over a white square.

Covid trial participants ‘at disadvantage’ for proving vaccination status

Concerns have been raised people taking part in Novavax trials cannot prove their vaccination status.

Hundreds of north-east Covid trial participants are being left at a “disadvantage” with struggles to prove their vaccination status.

More than 430 people from the NHS Grampian area are taking part in a UK-wide study on the effects of the Novavax jab to combat coronavirus.

But many have been unable to access these details on the NHS Inform website, it has emerged, as some IT systems are yet to be updated.

While there are no concrete plans yet, certificates proving people have received the jab could be required when travelling internationally or attending certain events in the future.

Some popular holiday destinations already require proof before allowing visitors in.

Douglas Lumsden, who is participating in the Novavax trial, has raised concerns about people accessing their vaccination status.
Douglas Lumsden, who is participating in the Novavax trial, has raised concerns about people accessing their vaccination status.

North-east MSP Douglas Lumsden is one of the trial participants, and has been contacted by several others in a similar position.

He is concerned people contacted by catch-up services or their GPs – unaware they have been vaccinated – could appear as “refuseniks” if their information is not fully updated.

The Scottish Conservative representative has written to Health Secretary Humza Yousaf for guidance on the matter, and said: “At present, there appears to be no way for these volunteers to download their vaccination status from the NHS Inform website.

“I am sure you agree that those taking part in any clinical trial play an important role in combatting serious health conditions, or in this case, the fight against Covid-19 and that in performing such a vital civic duty, should not be placed at a disadvantage.

“I have concern that should this anomaly not be resolved, it may deter others from taking part in medical trials in the future and would therefore urge you to investigate this issue and push for a speedy resolution.”

Work ‘ongoing’

Earlier this month the UK’s deputy chief medical officer, Professor Jonathan Van Tam, issued an open letter to trial participants saying they will not be left disadvantaged compared to people who received standard vaccines.

The National Institute For Health Research (NIHR) has also confirmed people who have taken part in a trial have “the same status” as others.

In a statement, the body acknowledged the “frustration” some participants are facing, and said it is working to resolve the matter quickly.

A Scottish Government spokesman said: “We are extremely grateful to everyone who has volunteered for vaccine trials in Scotland.

“They have all made a tremendous contribution to tackling the Covid-19 pandemic.

“We are committed to ensuring that these volunteers are not disadvantaged in any way, and work is ongoing to ensure their vaccine status is correctly shown on NHS systems.

“However, it’s important to note that we have no plans to make vaccine certification a requirement of access to services.”

Novavax trials: What’s happening?

More than 15,000 people aged 18-84 across the UK are taking part in clinical trials for the Novavax Covid-19 vaccine.

Earlier this month a study in the US and Mexico showed it was 100% effective against preventing moderate or severe disease.

Novavax started a rolling review process with the Medicines And Healthcare Products Regulatory Agency (MHRA) in January, and will file for regulatory approval later this year.

The UK government has ordered 60 million doses.

The Novavax jab works differently to the existing Pfizer, Moderna, Oxford-AstraZeneca and Janssen vaccines currently available – using cells which were initially taken from a moth.

Read our guide to the Covid vaccines and their contents here, for more information.